Literature DB >> 24661758

Novel mutation c.597_598dup in exon 5 of ABCC8 gene causing congenital hyperinsulinism.

Radhika Jindal1, Ayesha Ahmad2, Mohammad Asim Siddiqui3, Inderpal Singh Kochar2, Subhash Kumar Wangnoo3.   

Abstract

Congenital hyperinsulinism (CHI), a clinically and genetically heterogeneous disease, characterized by the unregulated secretion of insulin from pancreatic β-cells, is the most common cause of persistent hypoglycemia in infancy. Early diagnosis and maintenance of normoglycaemia are essential to prevent adverse neurodevelopmental outcomes. The most common and severe forms of CHI are caused by inactivating mutations in ABCC8 and KCNJ11 genes, encoding the two subunits of the pancreatic β-cell ATP sensitive potassium channel (KATP). We report a case of neonatal CHI due to a novel homozygous recessive mutation in the ABCC8 gene.
Copyright © 2013 Diabetes India. Published by Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Congenital hyperinsulinism (CHI); Genes; Insulin; Mutations; Recessive; β-Cells

Mesh:

Substances:

Year:  2013        PMID: 24661758     DOI: 10.1016/j.dsx.2013.02.018

Source DB:  PubMed          Journal:  Diabetes Metab Syndr        ISSN: 1871-4021


  2 in total

Review 1.  Somatostatin analogues for the treatment of hyperinsulinaemic hypoglycaemia.

Authors:  Basma Haris; Saras Saraswathi; Khalid Hussain
Journal:  Ther Adv Endocrinol Metab       Date:  2020-12-02       Impact factor: 3.565

2.  Pasireotide treatment for severe congenital hyperinsulinism due to a homozygous ABCC8 mutation.

Authors:  Christiaan F Mooij; Carline E Tacke; Mirjam E van Albada; Winfried Barthlen; Hennie Bikker; Klaus Mohnike; Matthijs W N Oomen; A S Paul van Trotsenburg; Nitash Zwaveling-Soonawala
Journal:  Ann Pediatr Endocrinol Metab       Date:  2021-05-07
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.